Long-standing malignant pancreatic carcinoid treated with octreotide

Riferimento: 
Rev Esp Enferm Dig. 2010 Nov;102(11):662-6.
Autori: 
Varas-Lorenzo MJ.
Fonte: 
Rev Esp Enferm Dig. 2010 Nov;102(11):662-6.
Anno: 
2010
Azione: 
Tumore carcinoide maligno al pancreas metastatico, in sequenza, è stato trattato con chemioterapia, interferone e octreotide a lunga durata d'azione.
Target: 
Chemioterapia-interferone-octreotide a lunga durata d'azione/tumore carcinoide maligno al pancreas.

ABSTRACT
A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreoscan; he sequentially received chemotherapy, interferon and octreotide, with long-term, 12-year survival after diagnosis. Given this unusual case, the second reported in our country, the overall literature is reviewed.
Free full text